Manufacturer of Controlled Substances; Notice of Application; IRIX Manufacturing, Inc., 49546 [2013-19616]
Download as PDF
<![CDATA[
49546
Federal Register / Vol. 78, No. 157 / Wednesday, August 14, 2013 / Notices
conventions, or protocols in effect on
May 1, 1971.
DEA has investigated Arizona
Department of Corrections, ASPCFlorence to ensure that its registration is
consistent with the public interest. The
investigation has included inspection
and testing of the Arizona Department
of Corrections, ASPC-Florence facility’s
physical security systems, verification
of its compliance with state and local
laws, and a review of its background
and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR § 1301.34, the above named
company is granted registration as an
importer of the basic class of controlled
substance listed.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
tkelley on DSK3SPTVN1PROD with NOTICES
Importer of Controlled Substances,
Notice of Registration, Wildlife
Laboratories Inc.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug
By Notice dated May 14, 2013, and
published in the Federal Register on
May 22, 2013, 78 FR 30329, Wildlife
Laboratories Inc., 1401 Duff Drive, Suite
400, Fort Collins, Colorado 80524, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Etorphine (except HCI) (9056), a basic
class of controlled substance listed in
schedule I.
The company plans to import the
listed controlled substance for sale to its
customer.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Wildlife Laboratories Inc. to import the
basic class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Wildlife Laboratories
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Jkt 229001
[FR Doc. 2013–19621 Filed 8–13–13; 8:45 am]
This is notice that on June 10, 2013,
Siegfried USA, LLC., 33 Industrial Park
Road, Pennsville, New Jersey 08070,
made application by letter to the Drug
Enforcement Administration (DEA) for
registration as an importer of the
following basic classes of controlled
substances:
[FR Doc. 2013–19637 Filed 8–13–13; 8:45 am]
16:16 Aug 13, 2013
Dated: August 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Importer of Controlled Substances;
Notice of Application; Siegfried USA,
LLC
Dated: August 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
VerDate Mar<15>2010
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR § 1301.34, the above named
company is granted registration as an
importer of the basic class of controlled
substance listed.
Schedule
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
II
II
The company plans to import the
listed controlled substances to bulk
manufacture API’S for distribution to its
customer.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
As noted in a previous notice
published in the Federal Register on
September 23, 1975, 40 FR 43745, all
applicants for registration to import a
basic classes of any controlled
substances in schedule I or II are, and
will continue to be, required to
demonstrate to the Deputy Assistant
Administrator, Office of Diversion
Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: August 2, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–19745 Filed 8–13–13; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application;
IRIX Manufacturing, Inc.
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on January 18, 2013,
IRIX Manufacturing, Inc., 309 Delaware
Street, Greenville, South Carolina
29605, made application to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Noroxymorphone (9668), a basic class of
controlled substance listed in schedule
II.
The company plans to manufacture
the listed controlled substance as API
for clinical trials.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substance,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than October 15, 2013.
Dated: August 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–19616 Filed 8–13–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Wildlife Laboratories, Inc.
By Notice dated April 16, 2013, and
published in the Federal Register on
April 23, 2013, 78 FR 23958, Wildlife
Laboratories, Inc., 1230 W. Ash Street,
Suite D, Windsor, Colorado 80550,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of Carfentanil (9743), a
basic class of controlled substance listed
in schedule II.
The company plans to manufacture
the above listed controlled substance for
sale to veterinary pharmacies, zoos, and
for other animal and wildlife
applications.
E:\FR\FM\14AUN1.SGM
14AUN1
]]>Agencies
[Federal Register Volume 78, Number 157 (Wednesday, August 14, 2013)]
[Notices]
[Page 49546]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-19616]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application;
IRIX Manufacturing, Inc.
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on January 18, 2013, IRIX
Manufacturing, Inc., 309 Delaware Street, Greenville, South Carolina
29605, made application to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of Noroxymorphone (9668), a basic
class of controlled substance listed in schedule II.
The company plans to manufacture the listed controlled substance as
API for clinical trials.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substance, may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than October 15, 2013.
Dated: August 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-19616 Filed 8-13-13; 8:45 am]
BILLING CODE 4410-09-P
